232 related articles for article (PubMed ID: 20602913)
1. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
[TBL] [Abstract][Full Text] [Related]
3. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
[TBL] [Abstract][Full Text] [Related]
4. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
[TBL] [Abstract][Full Text] [Related]
5. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
6. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.
Newton-Bishop JA; Chang YM; Iles MM; Taylor JC; Bakker B; Chan M; Leake S; Karpavicius B; Haynes S; Fitzgibbon E; Elliott F; Kanetsky PA; Harland M; Barrett JH; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2043-54. PubMed ID: 20647408
[TBL] [Abstract][Full Text] [Related]
7. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
[TBL] [Abstract][Full Text] [Related]
8. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
Laino AM; Berry EG; Jagirdar K; Lee KJ; Duffy DL; Soyer HP; Sturm RA
Br J Dermatol; 2018 May; 178(5):1119-1127. PubMed ID: 29315480
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.
Peña-Chilet M; Blanquer-Maceiras M; Ibarrola-Villava M; Martinez-Cadenas C; Martin-Gonzalez M; Gomez-Fernandez C; Mayor M; Aviles JA; Lluch A; Ribas G
BMC Cancer; 2013 Mar; 13():160. PubMed ID: 23537197
[TBL] [Abstract][Full Text] [Related]
10. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
Duffy DL; Zhu G; Li X; Sanna M; Iles MM; Jacobs LC; Evans DM; Yazar S; Beesley J; Law MH; Kraft P; Visconti A; Taylor JC; Liu F; Wright MJ; Henders AK; Bowdler L; Glass D; Ikram MA; Uitterlinden AG; Madden PA; Heath AC; Nelson EC; Green AC; Chanock S; Barrett JH; Brown MA; Hayward NK; MacGregor S; Sturm RA; Hewitt AW; ; Kayser M; Hunter DJ; Newton Bishop JA; Spector TD; Montgomery GW; Mackey DA; Smith GD; Nijsten TE; Bishop DT; Bataille V; Falchi M; Han J; Martin NG
Nat Commun; 2018 Nov; 9(1):4774. PubMed ID: 30429480
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
[TBL] [Abstract][Full Text] [Related]
12. IRF4 rs12203592 functional variant and melanoma survival.
Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
[TBL] [Abstract][Full Text] [Related]
13. Association of interferon regulatory factor 4 gene polymorphisms rs12203592 and rs872071 with skin cancer and haematological malignancies susceptibility: a meta-analysis of 19 case-control studies.
Wang S; Yan Q; Chen P; Zhao P; Gu A
BMC Cancer; 2014 Jun; 14():410. PubMed ID: 24906573
[TBL] [Abstract][Full Text] [Related]
14. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
[No Abstract] [Full Text] [Related]
15. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles.
Bataille V; Snieder H; MacGregor AJ; Sasieni P; Spector TD
J Natl Cancer Inst; 2000 Mar; 92(6):457-63. PubMed ID: 10716963
[TBL] [Abstract][Full Text] [Related]
16. Higher Nevus Count Exhibits a Distinct DNA Methylation Signature in Healthy Human Skin: Implications for Melanoma.
Roos L; Sandling JK; Bell CG; Glass D; Mangino M; Spector TD; Deloukas P; Bataille V; Bell JT
J Invest Dermatol; 2017 Apr; 137(4):910-920. PubMed ID: 27993549
[TBL] [Abstract][Full Text] [Related]
17. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
Taylor NJ; Mitra N; Goldstein AM; Tucker MA; Avril MF; Azizi E; Bergman W; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cannon-Albright LA; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes AM; Ghiorzo P; Grazziotin TC; Hansson J; Harland M; Hayward NK; Hocevar M; Höiom V; Ingvar C; Landi MT; Landman G; Larre-Borges A; Leachman SA; Mann GJ; Nagore E; Olsson H; Palmer JM; Perić B; Pjanova D; Pritchard A; Puig S; van der Stoep N; Wadt KAW; Whitaker L; Yang XR; Newton Bishop JA; Gruis NA; Kanetsky PA;
J Invest Dermatol; 2017 Dec; 137(12):2606-2612. PubMed ID: 28830827
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia.
James MR; Hayward NK; Dumenil T; Montgomery GW; Martin NG; Duffy DL
J Invest Dermatol; 2004 Oct; 123(4):760-2. PubMed ID: 15373782
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
